Live feed12:18:00·136dPRReleasevia Quantisnow+2Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval StandardsByQuantisnow·Wall Street's wire, on your screen.CNTX· Context Therapeutics Inc.IMNM· Immunome Inc.ONCY· Oncolytics Biotech Inc.PRLD· Prelude Therapeutics IncorporatedRLAY· Relay Therapeutics Inc.Health Care